Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Hirotoshi Echizen
ResearcherPublications, citations & collaboration network
Hirotoshi Echizen is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 151 works, 3,968 citations, an h-index of 31 and an i10-index of 58.
151
Works
3,968
Citations
31
h-index
58
i10-index
IDs:OpenAlex
How has Hirotoshi Echizen's publication output changed over time?
ScholarIQpublication output · 1985–2016
Output grew0% over the shown period — from 1 works in 1985 to 1 in 2016.
1
1
2
2
1
1
1
1
1
198519861998200120032006201020152016
What are the most-cited papers on Hirotoshi Echizen?
ScholarIQmost cited works
Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans
Harumi Takahashi, G. Wilkinson, Edith A. Nutescu, Takashi Morita, Marylyn D. Ritchie, Maria Gabriella Scordo, Vittorio Pengo, Martina Barban, Roberto Padrini, Ichiro Ieiri, Kenji Otsubo, Toshitaka Kashima, Sosuke Kimura, Shinichi Kijima, Hirotoshi Echizen
S192301155. 2006375 CitationsOPEN ACCESS
Pharmacogenetics of Warfarin Elimination and its Clinical Implications
Harumi Takahashi, Hirotoshi Echizen
S69290020. 2001314 Citations
The First-in-Class Potassium-Competitive Acid Blocker, Vonoprazan Fumarate: Pharmacokinetic and Pharmacodynamic Considerations
Hirotoshi Echizen
S69290020. 2015201 CitationsOPEN ACCESS
Population differences in S‐warfarin metabolism between <i>CYP2C9</i> genotype‐matched Caucasian and Japanese patients
Harumi Takahashi, G. Wilkinson, Yoseph Caraco, Mordechai Muszkat, Richard B. Kim, Toshitaka Kashima, Sosuke Kimura, Hirotoshi Echizen
S159852663. 2003190 Citations
Clinical Pharmacokinetics of Verapamil, Nifedipine and Diltiazem
Hirotoshi Echizen, Michel Eichelbaum
S69290020. 1986187 Citations
Related on ScholarIQ
Meiji Pharmaceutical University
Institution
Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans
Paper
Pharmacogenetics of Warfarin Elimination and its Clinical Implications
Paper
The First-in-Class Potassium-Competitive Acid Blocker, Vonoprazan Fumarate: Pharmacokinetic and Pharmacodynamic Considerations
Paper
Population differences in S‐warfarin metabolism between <i>CYP2C9</i> genotype‐matched Caucasian and Japanese patients
Paper
Clinical Pharmacokinetics of Verapamil, Nifedipine and Diltiazem
Paper